These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 38138293)

  • 41. Phosphodiesterase 5 attenuates the vasodilatory response in renovascular hypertension.
    Stegbauer J; Friedrich S; Potthoff SA; Broekmans K; Cortese-Krott MM; Quack I; Rump LC; Koesling D; Mergia E
    PLoS One; 2013; 8(11):e80674. PubMed ID: 24260450
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sildenafil citrate-restored eNOS and PDE5 regulation in sickle cell mouse penis prevents priapism via control of oxidative/nitrosative stress.
    Bivalacqua TJ; Musicki B; Hsu LL; Berkowitz DE; Champion HC; Burnett AL
    PLoS One; 2013; 8(7):e68028. PubMed ID: 23844149
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling.
    Li N; Xi Y; Tinsley HN; Gurpinar E; Gary BD; Zhu B; Li Y; Chen X; Keeton AB; Abadi AH; Moyer MP; Grizzle WE; Chang WC; Clapper ML; Piazza GA
    Mol Cancer Ther; 2013 Sep; 12(9):1848-59. PubMed ID: 23804703
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer's disease.
    Zuccarello E; Acquarone E; Calcagno E; Argyrousi EK; Deng SX; Landry DW; Arancio O; Fiorito J
    Biochem Pharmacol; 2020 Jun; 176():113818. PubMed ID: 31978378
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro.
    Jeremy JY; Ballard SA; Naylor AM; Miller MA; Angelini GD
    Br J Urol; 1997 Jun; 79(6):958-63. PubMed ID: 9202566
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phosphodiesterase 5 inhibitors as novel agents for the treatment of Alzheimer's disease.
    Liu L; Xu H; Ding S; Wang D; Song G; Huang X
    Brain Res Bull; 2019 Nov; 153():223-231. PubMed ID: 31493542
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Medicinal therapy of benign prostate syndrome with phosphodiesterase-5 inhibitors].
    Herlemann A; Gratzke C; Andersson KE; Sievert KD
    Urologe A; 2013 Feb; 52(2):204-11. PubMed ID: 23417046
    [TBL] [Abstract][Full Text] [Related]  

  • 48. L-cysteine/hydrogen sulfide pathway induces cGMP-dependent relaxation of corpus cavernosum and penile arteries from patients with erectile dysfunction and improves arterial vasodilation induced by PDE5 inhibition.
    La Fuente JM; Fernández A; Pepe-Cardoso AJ; Martínez-Salamanca JI; Louro N; Angulo J
    Eur J Pharmacol; 2019 Nov; 863():172675. PubMed ID: 31542487
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension.
    Schaffner D; Lazaro A; Deibert P; Hasselblatt P; Stoll P; Fauth L; Baumstark MW; Merfort I; Schmitt-Graeff A; Kreisel W
    World J Gastroenterol; 2018 Oct; 24(38):4356-4368. PubMed ID: 30344420
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cyclic guanosine monophosphate modulates accumulation of phosphodiesterase 5 inhibitors in human platelets.
    Bajraktari G; Burhenne J; Bugert P; Haefeli WE; Weiss J
    Biochem Pharmacol; 2017 Dec; 145():54-63. PubMed ID: 28964803
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Allosteric-site and catalytic-site ligand effects on PDE5 functions are associated with distinct changes in physical form of the enzyme.
    Corbin JD; Zoraghi R; Francis SH
    Cell Signal; 2009 Dec; 21(12):1768-74. PubMed ID: 19665054
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antidepressant-like effects of the phosphodiesterase-4 inhibitor etazolate and phosphodiesterase-5 inhibitor sildenafil via cyclic AMP or cyclic GMP signaling in mice.
    Wang C; Zhang J; Lu Y; Lin P; Pan T; Zhao X; Liu A; Wang Q; Zhou W; Zhang HT
    Metab Brain Dis; 2014 Sep; 29(3):673-82. PubMed ID: 24705918
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phosphodiesterase-5 Gln817 is critical for cGMP, vardenafil, or sildenafil affinity: its orientation impacts cGMP but not cAMP affinity.
    Zoraghi R; Corbin JD; Francis SH
    J Biol Chem; 2006 Mar; 281(9):5553-8. PubMed ID: 16407275
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of the NO/cGMP/K(ATP) pathway in the protective effects of sildenafil against ethanol-induced gastric damage in rats.
    Medeiros JV; Gadelha GG; Lima SJ; Garcia JA; Soares PM; Santos AA; Brito GA; Ribeiro RA; Souza MH
    Br J Pharmacol; 2008 Feb; 153(4):721-7. PubMed ID: 18071300
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells.
    Wharton J; Strange JW; Møller GM; Growcott EJ; Ren X; Franklyn AP; Phillips SC; Wilkins MR
    Am J Respir Crit Care Med; 2005 Jul; 172(1):105-13. PubMed ID: 15817798
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension.
    Lewis GD; Semigran MJ
    Curr Heart Fail Rep; 2004 Dec; 1(4):183-9. PubMed ID: 16036043
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects and mechanisms of action of sildenafil citrate in human chorionic arteries.
    Maharaj CH; O'Toole D; Lynch T; Carney J; Jarman J; Higgins BD; Morrison JJ; Laffey JG
    Reprod Biol Endocrinol; 2009 Apr; 7():34. PubMed ID: 19389232
    [TBL] [Abstract][Full Text] [Related]  

  • 58. cGMP-hydrolytic activity and its inhibition by sildenafil in normal and failing human and mouse myocardium.
    Vandeput F; Krall J; Ockaili R; Salloum FN; Florio V; Corbin JD; Francis SH; Kukreja RC; Movsesian MA
    J Pharmacol Exp Ther; 2009 Sep; 330(3):884-91. PubMed ID: 19546307
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of sildenafil on renin secretion in human subjects.
    Chiu YJ; Reid IA
    Exp Biol Med (Maywood); 2002 Sep; 227(8):620-5. PubMed ID: 12192104
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proconvulsant effects of sildenafil citrate on pilocarpine-induced seizures: Involvement of cholinergic, nitrergic and pro-oxidant mechanisms.
    de Carvalho MAJ; Chaves-Filho A; de Souza AG; de Carvalho Lima CN; de Lima KA; Rios Vasconcelos ER; Feitosa ML; Souza Oliveira JV; de Souza DAA; Macedo DS; de Souza FCF; de França Fonteles MM
    Brain Res Bull; 2019 Jul; 149():60-74. PubMed ID: 31004733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.